Top News: FireEye (NASDAQ:FEYE), Regeneron Pharmaceuticals (NASDAQ:REGN), Evoke Pharma (NASDAQ:EVOK), bluebird bio (NASDAQ:BLUE), Cytec Industries Inc. (NYSE:CYT)

On Thursday shares of FireEye, Inc. (NASDAQ:FEYE) closed at $41.30. Company’s sales growth for last 5 years was 205.50% and EPS growth for next 5 years is recorded as 35.00%. FireEye, Inc. (NASDAQ: FEYE), the leader at stopping today’s advanced cyber attacks, announced financial results for the first quarter of 2015. First quarter revenue was $125.4 million, an increase of 69 percent from the first quarter of 2014 and above the previously issued guidance range of $118 to $122 million. Total revenue included product revenue of $40.2 million, product subscription revenue of $43.4 million, support and maintenance revenue of $19.1 million and professional services revenue of $22.7 million.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in last trading activity fell -2.61% to close at $457.46. Company weekly performance is -4.71% while its quarterly performance stands at 10.33%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is -7.68% away from its 52 week high. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management presentations at the following investor conferences: Bank of America Merrill Lynch 2015 Healthcare Conference at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time) on Tuesday, May 12, 2015. Barclays 2015 Biotech CEO/CFO Conference Call Series at 11:00 a.m. Eastern Time on Thursday, May 14, 2015. Sanford C. Bernstein’s 31st Annual Strategic Decisions Conference at 4:00 p.m. Eastern Time on Wednesday, May 27, 2015.

On last trading day Evoke Pharma, Inc. (NASDAQ:EVOK) fell -1.44% to close at $6.17. Its volatility for the week is 5.14% while volatility for the month is 4.66%. Evoke Pharma, Inc. (NASDAQ:EVOK) monthly performance is -12.48%. Evoke Pharma, Inc. (NASDAQ:EVOK) announced that it will issue its financial results for the first quarter of 2015 on Thursday, May 14, 2015, after the close of the market.Evoke will hold a conference call on Thursday, May 14, 2015, at 4:30 p.m. ET to discuss the results.

bluebird bio, Inc. (NASDAQ:BLUE) has 1.10% insider ownership while its institutional ownership stands at 99.80%. In last trading activity company’s stock closed at $133.19. bluebird bio, Inc. (NASDAQ:BLUE) announced that members of the management team will participate in the following upcoming health care conferences: Deutsche Bank 40th Annual Health Care Conference on Thursday, May 7, 2015 from 8:40 to 9:15 a.m. ET at the Intercontinental Hotel in Boston. Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015 from 4:20 to 4:50 p.m. PT at the Encore at the Wynn Hotel in Las Vegas.

On last trading day Cytec Industries Inc. (NYSE:CYT) fell -1.02% to close at $55.29. Its volatility for the week is 1.52% while volatility for the month is 1.68%. CYT’s sales growth for past 5 years was -3.70% and its EPS growth for past 5 years was 76.40%. Cytec Industries Inc. (NYSE:CYT) monthly performance is 2.31%. Cytec Industries Inc. (NYSE:CYT) is carrying a Zacks Rank #2 (Buy).

Leave a Reply

Your email address will not be published. Required fields are marked *

*